Cours Prevail Therapeutics Inc.
Actions
PRVL
US74140Y1010
Recherche biotechnologique et médicale
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Franz Hefti
CEO | Chief Executive Officer | 76 | 01/03/18 |
Jeffrey Sevigny
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/03/18 |
Emily Minkow
PRN | Corporate Officer/Principal | 41 | 01/11/18 |
Varia. 1 janv. | Capi. | |
---|---|---|
-2,70% | 103 Md | |
+1,42% | 95,28 Md | |
+1,46% | 22,15 Md | |
-15,80% | 21,02 Md | |
-8,58% | 18,15 Md | |
-38,74% | 16,73 Md | |
-12,96% | 16,05 Md | |
+5,07% | 13,68 Md | |
+33,81% | 12,17 Md |